Sign Up to Receive Your Personalised Learning Resources
CONFERENCE HUB
Alessio Cortellini, ESMO Immuno-Oncology 2022: Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer
Start Learning
Alan Menter, Dermatology Meeting News 2023: Ixekizumab treatment for patients with moderate-to-severe plaque psoriasis
Amit G. Pandya, Dermatology Meeting News 2023: JAK inhibitors for the treatment of vitiligo
Latest insights on atopic dermatitis and prurigo nodularis
PoCOsteo: a rapid point-of-care device for improving patient adherence in osteoporosis: Patricia Khashayar, WCO-IOF-ESCEO 2023
Platelet Rich Plasma therapy for tendinopathies: Jean-François Kaux, WCO-IOF-ESCEO 2023
William Damsky, Dermatology Meeting News 2023: Current treatment paradigm and major challenges in treating inflammatory skin diseases
William Damsky, Dermatology Meeting News 2023: A personalised approach to treating inflammatory skin diseases
Achieving best practice management of primary biliary cholangitis, now and in the future
Ralph Mösges, AAAAI 2023: Mannan conjugated birch pollen allergoids for the treatment of birch pollen allergy
Victoria P. Werth, ACR 2022: Findings from the phase 2 LILAC study of BIIB059 in cutaneous lupus erythematosus
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Dupilumab as a therapeutic option for eosinophilic oesophagitis: Arjan Bredenoord, DDW 2023
View
Understanding the pathophysiology of multiple sclerosis and the development of new therapies
View
QUASAR: phase 3 study of guselkumab in moderately to severely active ulcerative colitis: Jessica Allegretti, DDW 2023
View
Comparison study of upadacitinib and tofacitinib as induction treatment in ulcerative colitis: Gil Y. Melmed, DDW 2023
View
Guselkumab: an investigational monoclonal antibody for ulcerative colitis: Jessica Allegretti, DDW 2023
View
UEG Digestive Health Month: Matthias Löhr, May 2023
View
Advances in the Treatment of Systemic Sclerosis
View
Simeng Lin, ECCO’23: Anti-TNF treatment failure in Crohn’s disease
View
Foreword – touchREVIEWS in RMD Vol 1 Issue 2 – 2022
View
Achieving best practice management of primary biliary cholangitis, now and in the future
View